Invention Grant
- Patent Title: Rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias
- Patent Title (中): 白血病体外清除方法
-
Application No.: US674247Application Date: 1996-07-01
-
Publication No.: US5773460APublication Date: 1998-06-30
- Inventor: Louis Gaboury , Luc Villeneuve , Richard Giasson , Tiechao Li , Ajay Kumar Gupta
- Applicant: Louis Gaboury , Luc Villeneuve , Richard Giasson , Tiechao Li , Ajay Kumar Gupta
- Applicant Address: CAX Montreal
- Assignee: Universite De Montreal
- Current Assignee: Universite De Montreal
- Current Assignee Address: CAX Montreal
- Main IPC: A61K41/00
- IPC: A61K41/00 ; C07D311/82 ; A61K31/35
Abstract:
The present invention relates to novel photoactivable rhodamine derivatives for enhancing high quantum-yield production and singlet oxygen generation upon irradiation with light while maintaining desirable differential retention of rhodamine between normal and cancer cells. Representative derivatives are 2-(4,5-dibromo-6-amino-3-imino-3H-xanthen-9-yl)-benzoic acid methyl ester hydrochloride; 2-(4, 5-dibromo-6-amino-3-imino-3H-xanthen-9-yl)-benzoic acid ethyl ester hydrochloride; 2-(4,5-dibromo-6-amino-3-imino-3H-xanthen-9-yl)-benzoic acid octyl ester hydrochloride; 2-(4,5-dibromo-6-amino-3-imino-3H-xanthen-9-yl)-benzoic acid n-butyl ester hydrochloride; 2-(6-ethyl amino-3-ethyl imino-3H-xanthen-9-yl)-benzoic acid n-butyl ester hydrochloride; and photoactivable derivatives thereof. These derivatives are utilized in an amount to achieve appropriate intracellular levels of the derivative when irradiation of a suitable wavelength and intensity is applied to photoactivate the derivative and thereby induce cell killing.
Public/Granted literature
- US5150174A Photoelectric color sensor Public/Granted day:1992-09-22
Information query